Garrido Garcia, Alícia (Date of defense: 2022-11-10)
[eng] BACKGROUND:
High-risk neuroblastoma (NB) represents a heterogeneous group of tumors, whereby patients can display response to treatment and long-term outcome or develop early progressive, chemoresistant disease with ...